Abstracts by keywords: polypharmacy; anti-dementia therapy initiation; dementia; retrospective study
Association between polypharmacy and initiation of anti-dementia therapy in German general practices
Dementia is a chronic disease that affects between 5 % and 7 % of people aged 60 years and over [1]. The number of people suffering from dementia is expected to rise to 66 million worldwide by 2030 and to 115 million by 2050. In Germany the prevalence is very high with over a million people suffering from dementia [2]. Since dementia is associated with poor quality of life [3] and psychiatric disorders (e.g. depression and anxiety) [4,5], there is a need for better prevention, diagnosis, treatment and management measures regarding this neurodegenerative disease.